BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21738355)

  • 21. Adult polyglucosan body disease in a patient originally diagnosed with Fabry's disease.
    Sagnelli A; Savoiardo M; Marchesi C; Morandi L; Mora M; Morbin M; Farina L; Mazzeo A; Toscano A; Pagliarani S; Lucchiari S; Comi GP; Salsano E; Pareyson D
    Neuromuscul Disord; 2014 Mar; 24(3):272-6. PubMed ID: 24380807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fabry's disease--a comprehensive review on pathogenesis, diagnosis and treatment.
    Mahmud HM
    J Pak Med Assoc; 2014 Feb; 64(2):189-94. PubMed ID: 24640811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiopulmonary involvement in Fabry's disease.
    Koskenvuo JW; Kantola IM; Nuutila P; Knuuti J; Parkkola R; Mononen I; Hurme S; Kalliokoski R; Viikari JS; Wendelin-Saarenhovi M; Kiviniemi TO; Hartiala JJ
    Acta Cardiol; 2010 Apr; 65(2):185-92. PubMed ID: 20458826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enzyme replacement therapy in Fabry's disease: recent advances and clinical applications.
    Mignani R; Cagnoli L
    J Nephrol; 2004; 17(3):354-63. PubMed ID: 15365954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular genetic, biochemical, and clinical studies in three families with cardiac Fabry's disease.
    Yoshitama T; Nakao S; Takenaka T; Teraguchi H; Sasaki T; Kodama C; Tanaka A; Kisanuki A; Tei C
    Am J Cardiol; 2001 Jan; 87(1):71-5. PubMed ID: 11137837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Multisystem lesions in orphan diseases: rheumatological aspects of Fabry's disease. Case report].
    Mashkunova OV; Isabekova AH; Botabekova AZ; Novikov PI
    Ter Arkh; 2023 Aug; 95(6):505-510. PubMed ID: 38158971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of recombinant human alpha-galactosidase A replacement therapy in Fabry's disease.
    Eng CM; Guffon N; Wilcox WR; Germain DP; Lee P; Waldek S; Caplan L; Linthorst GE; Desnick RJ;
    N Engl J Med; 2001 Jul; 345(1):9-16. PubMed ID: 11439963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fabry's disease.
    El-Abassi R; Singhal D; England JD
    J Neurol Sci; 2014 Sep; 344(1-2):5-19. PubMed ID: 25106696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibroblast alpha-galactosidase A activity for identification of Fabry's disease heterozygotes.
    Fensom AH; Benson PF; Grant AR; Jacobs L
    J Inherit Metab Dis; 1980; 2(1):9-12. PubMed ID: 6273649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of renal ectopia with Fabry's disease in 3 patients.
    Rákóczi E; Tóth B; Görögh S; Erdos M; Sümegi J; Maródi L
    J Urol; 2009 Apr; 181(4):1949-54. PubMed ID: 19237168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Fabry's disease; towards a treatment].
    Linthorst GE; Hollak CE; Bosman DK; Heymans HS; Aerts JM
    Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2391-5. PubMed ID: 11145093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of symptomatic heterozygous female Fabry's disease without detectable mutation in the alpha-galactosidase gene.
    Handa Y; Yotsumoto S; Isobe E; Sai Y; Yoshii N; Nakao S; Fujita N; Hamaguchi S; Kanzaki T
    Dermatology; 2000; 200(3):262-5. PubMed ID: 10828639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fabry's disease--a case report and review of literatures reported in Korea.
    Lee SY; Kim SJ; Lee JI; Kim ES; Lee CH; Kim JH; Jeong HJ; Ha SK
    Yonsei Med J; 1998 Feb; 39(1):67-72. PubMed ID: 9529988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Enzyme replacement therapy in Fabry's disease].
    Alvarez L; del Pozo C; Trigueros M; Sánchez L; Albero MD; López-Menchero R; Ortega E
    Nefrologia; 2005; 25(3):322-7. PubMed ID: 16053014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Fabry disease in light of recent review].
    Uyama E
    Brain Nerve; 2008 Nov; 60(11):1235-44. PubMed ID: 19069157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ocular findings in Fabry's disease].
    Kuzman T; Juri J; Mrsić M; Jeren-Strujić B; Mandić Z; Sikić J
    Acta Med Croatica; 2006; 60(2):163-6. PubMed ID: 16848212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional evaluation of a novel GLA causative mutation in Fabry disease.
    Li P; Zhang L; Xiong Q; Wang Z; Cui X; Zhou YA; Wang Y; Xiao H; Wu C
    Mol Genet Genomic Med; 2019 Sep; 7(9):e864. PubMed ID: 31321922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of Anderson-Fabry Disease.
    Simonetta I; Tuttolomondo A; Daidone M; Miceli S; Pinto A
    Curr Pharm Des; 2020; 26(40):5089-5099. PubMed ID: 32183665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Myocardial disease in inherited disease].
    Nakao S
    Nihon Rinsho; 2000 Jan; 58(1):200-3. PubMed ID: 10885314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atypical Fabry's disease. An oligosymptomatic variant.
    Ko YH; Kim HJ; Roh YS; Park CK; Kwon CK; Park MH
    Arch Pathol Lab Med; 1996 Jan; 120(1):86-9. PubMed ID: 8554452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.